Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Jul;58(7):488-96.
doi: 10.1136/adc.58.7.488.

Hepatitis B virus associated membranous glomerulonephritis

Hepatitis B virus associated membranous glomerulonephritis

J Wiggelinkhuizen et al. Arch Dis Child. 1983 Jul.

Abstract

The incidence of persistent hepatitis B surface (HBs) antigenaemia was studied in 114 nephrotic children with glomerulonephritis. Twenty five (24 boys) of 28 cases of membranous glomerulonephritis were HBs antigen (HBsAg) carriers. Only 9 of the remaining 86 patients with nephropathies other than membranous glomerulonephritis were HBsAg positive. HBsAg immune complexes were seen in the sera by electron microscopy. On radioimmunoassay both HBsAg and antibody (anti-HBs), and HBeAg and antibody (anti-HBe) were often detected concurrently, HBsAg was not shown in the glomerular capillary wall. HBs antigenaemia persisted in 80% of patients after recovery from glomerulonephritis but remission of the proteinuria correlated well, although not fully, with seroconversion to anti-HBe. The natural history of hepatitis B virus (HBV) associated glomerulonephritis in childhood is one of slow recovery. A few patients are left with mild asymptomatic proteinuria but progressive renal failure is rare. The 14% incidence of membranous glomerulonephritis in nephrotic children in this area is much higher than that found by the international study of kidney disease in children in well developed countries and is probably related to a high HBV carrier rate. A search for HBV markers should be included in the investigation of persistent glomerulonephritis, particularly in countries with a high prevalence of HBV carriers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Med. 1968 Apr;44(4):493-8 - PubMed
    1. Lancet. 1971 Jul 31;2(7718):234-7 - PubMed
    1. J Clin Pathol. 1973 Mar;26(3):209-16 - PubMed
    1. S Afr Med J. 1973 Jun 2;47(21):911-2 - PubMed
    1. Am J Clin Pathol. 1973 Aug;60(2):222-8 - PubMed

LinkOut - more resources